| BCBS Oklahoma Medical Policies | Burosumab-twza | 2025-10-01 |
| BCBS Oklahoma Medical Policies | Chromoendoscopy as an Adjunct to Colonoscopy | 2025-10-01 |
| BCBS Oklahoma Medical Policies | Denosumab (Prolia & Xgeva) and Associated Biosimilars | 2025-10-01 |
| BCBS Oklahoma Medical Policies | Gene Therapy for Inherited Retinal Dystrophy | 2025-10-01 |
| BCBS Oklahoma Medical Policies | Infrared Therapy Devices | 2025-10-01 |
| BCBS Oklahoma Medical Policies | Lanreotide | 2025-10-01 |
| BCBS Oklahoma Medical Policies | Romiplostim | 2025-10-01 |
| BCBS Oklahoma Medical Policies | Surface Electromyography and Paraspinal Surface | 2025-10-01 |
| BCBS Oklahoma Medical Policies | Wilate | 2025-10-01 |
| BCBS New Mexico Medical Policies | Burosumab-twza | 2025-10-01 |